Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer

被引:1
作者
Declercq, Isabelle [1 ,2 ]
Lievens, Yolande
Verbeken, Eric
Vansteenkiste, Johan [1 ,2 ]
机构
[1] Univ Hosp Gasthuisberg, Resp Oncol Unit Pulmonol, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Leuven Lung Canc Grp, B-3000 Louvain, Belgium
关键词
pemetrexed; rash; non-small cell lung cancer; radiotherapy;
D O I
10.1097/JTO.0b013e318170fcb9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:662 / 663
页数:2
相关论文
共 50 条
[41]   A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer [J].
Tanai, Chiharu ;
Yamamoto, Nobuyuki ;
Ohe, Yuichiro ;
Takahashi, Toshiaki ;
Kunitoh, Hideo ;
Murakami, Haruyasu ;
Yamamoto, Noboru ;
Nakamura, Yukiko ;
Nokihara, Hiroshi ;
Shukuya, Takehito ;
Baldwin, John R. ;
Koshiji, Minori ;
Tamura, Tomohide .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) :1068-1074
[42]   Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer [J].
Cohen, Martin H. ;
Justice, Robert ;
Pazdur, Richard .
ONCOLOGIST, 2009, 14 (09) :930-935
[43]   Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer [J].
Markova, Boyka ;
Haehnel, Patricia S. ;
Kasper, Stefan ;
Herbertz, Stephan ;
Schuler, Martin ;
Breitenbuecher, Frank .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (04) :545-554
[44]   Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients [J].
Honore, Per Hartvig ;
Joensen, Sigrid Johansdottir ;
Olsen, Michelle ;
Hansen, Steen Honore ;
Mellemgaard, Anders .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) :349-357
[45]   Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer [J].
Li, Zhi ;
Pan, Shuya ;
Tian, Yuan ;
Liu, Shaowei ;
Wei, Weifeng ;
Wang, Jinlin ;
Chen, Tianfeng ;
Wang, Ling .
CHINESE CHEMICAL LETTERS, 2024, 35 (12)
[46]   Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer [J].
Boyka Markova ;
Patricia S. Hähnel ;
Stefan Kasper ;
Stephan Herbertz ;
Martin Schuler ;
Frank Breitenbuecher .
Journal of Cancer Research and Clinical Oncology, 2012, 138 :545-554
[47]   Non-small cell lung cancer [J].
Adamietz, I. A. ;
Niederle, N. .
ONKOLOGE, 2010, 16 (06) :63-74
[48]   Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients [J].
Per Hartvig Honoré ;
Sigrid Jóhansdóttir Joensen ;
Michelle Olsen ;
Steen Honoré Hansen ;
Anders Mellemgaard .
Cancer Chemotherapy and Pharmacology, 2014, 74 :349-357
[49]   Brief Report of Biweekly Pemetrexed and Gemcitabine in Elderly Patients with Non-small Cell Lung Cancer [J].
Sequist, Lecia V. ;
Fidias, Panos ;
Heist, Rebecca S. ;
Ostler, Patricia ;
Muzikansky, Alona ;
Lynch, Thomas J. .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :1170-1173
[50]   ACTIVITY OF S-1 FOR NON-SMALL CELL LUNG CANCER PRETREATED WITH OR WITHOUT PEMETREXED [J].
Takagi, Yusuke ;
Nakahara, Yoshiro ;
Yomota, Makiko ;
Okuma, Yusuke ;
Mikura, Shinichiro ;
Hosomi, Yukio ;
Shibuya, Masahiko ;
Okamura, Tatsuru .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S566-S566